For glucose uptake assay, neutrophils (0.5 × 106) in glucose-free RPMI medium supplemented with the fluorescent glucose analogue 2-deoxy-2-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-D-glucose (2-NBDG, Invitrogen, 30 µM, N13195) were activated with Zy/op (100 µg/mL) for 30 min, at 37 °C and 5% CO2. Neutrophils were washed twice in PBS and immediately analysed by flow cytometry.
To evaluate the expression of surface antigens, neutrophils were incubated with specific antibodies to GLUT1 (1:200, Abcam, Cat# ab209449), Ly6G (1:200, BD Bioscience, Cat# 560599) CD15 (1:100, BD, Cat# 562370) or CD11b (1:200, Biolegend, Cat# 101212) or the appropriate isotype controls for 1 h. Viable cells were assessed by incubating cells with Fixable Viability Dye (Thermo).
The fluorescence of samples was measured in a flow cytometer (FACSVerse™, BD Biosciences) and analysed using FlowJo software (Tree Star). Ten thousand cells were analysed52 (link).